Home/Filings/4/0001415889-24-010138
4//SEC Filing

NOYES TIMOTHY P 4

Accession 0001415889-24-010138

CIK 0001798749other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 6:00 PM ET

Size

14.3 KB

Accession

0001415889-24-010138

Insider Transaction Report

Form 4
Period: 2024-04-01
NOYES TIMOTHY P
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-01$2.14/sh+10,000$21,40010,000 total
  • Sale

    Common Stock

    2024-04-01$28.96/sh4,502$130,3995,498 total
  • Sale

    Common Stock

    2024-04-01$31.02/sh2,851$88,4461,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-04-0110,000373,381 total
    Exercise: $2.14Exp: 2031-04-01Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2024-04-01$29.90/sh1,647$49,2383,851 total
  • Sale

    Common Stock

    2024-04-01$31.95/sh1,000$31,9500 total
Footnotes (5)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.57 to $29.48, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.705 to $30.45, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.73 to $31.46, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F5]A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Issuer

Aerovate Therapeutics, Inc.

CIK 0001798749

Entity typeother

Related Parties

1
  • filerCIK 0001185035

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:00 PM ET
Size
14.3 KB